VF
LRMR icon

Virtu Financial’s Larimar Therapeutics LRMR Stock Holding History

Virtu Financial’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-51,791
Closed -$233K – 1958
2026
Q1 		$233K Buy
+51,791
New +$207K 0.01% 946
2025
Q4 		– Sell
-102,680
Closed -$332K – 1982
2025
Q3 		$332K Buy
102,680
+55,920
+120% +$210K 0.02% 705
2025
Q2 		$135K Buy
+46,760
New +$108K 0.01% 991
2024
Q4 		– Sell
-10,843
Closed -$71K – 1826
2024
Q3 		$71K Buy
+10,843
New +$87.1K ﹤0.01% 959
2024
Q2 		– Sell
-17,578
Closed -$133K – 1632
2024
Q1 		$133K Buy
+17,578
New +$137K 0.01% 875
2023
Q2 		– Sell
-32,185
Closed -$146K – 1806
2023
Q1 		$146K Buy
+32,185
New +$168K 0.02% 849
2019
Q4 		$117K Buy
+8,781
New +$83.9K 0.01% 1056
2019
Q3 		– Sell
-996
Closed -$14K – 1651
2019
Q2 		$14K Buy
+996
New +$26.5K ﹤0.01% 1372
2017
Q4 		– Sell
-1,572
Closed -$66K – 2723
2017
Q3 		$66K Buy
+1,572
New +$65.4K ﹤0.01% 2170

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Virtu Financial's LRMR Position: Q2 2026 in Review

Virtu Financial sold out of Larimar Therapeutics (LRMR) in Q2 2026, closing a stake of 51,791 shares — an estimated $233K sold.

Virtu Financial first reported a position in LRMR in Q3 2017 and held it in 9 quarters. The position peaked at $332K in Q3 2025. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Virtu Financial reported no remaining Larimar Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 51,791 Larimar Therapeutics shares in Q2 2026, an estimated $233K.
  • Virtu Financial first reported a position in Larimar Therapeutics in Q3 2017 and held it in 9 quarters.
  • Virtu Financial's Larimar Therapeutics position peaked at $332K in Q3 2025.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.